These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 8253704)

  • 1. The comparative pharmacology of new antidepressants.
    Leonard BE
    J Clin Psychiatry; 1993 Aug; 54 Suppl():3-15; discussion 16-7. PubMed ID: 8253704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH; Goa KL
    CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Other Antidepressants.
    Schwasinger-Schmidt TE; Macaluso M
    Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders.
    Gunasekara NS; Noble S; Benfield P
    Drugs; 1998 Jan; 55(1):85-120. PubMed ID: 9463792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism.
    Preskorn SH
    Clin Pharmacokinet; 1997; 32 Suppl 1():1-21. PubMed ID: 9068931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Selective serotonin reuptake inhibitor(SSRI)].
    Motohashi N
    Nihon Rinsho; 2001 Aug; 59(8):1519-22. PubMed ID: 11519151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding.
    Sánchez C; Hyttel J
    Cell Mol Neurobiol; 1999 Aug; 19(4):467-89. PubMed ID: 10379421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective serotonin reuptake inhibitors: pharmacologic profiles and potential therapeutic distinctions.
    Finley PR
    Ann Pharmacother; 1994 Dec; 28(12):1359-69. PubMed ID: 7696728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How do antidepressants affect serotonin receptors? The role of serotonin receptors in the therapeutic and side effect profile of the SSRIs.
    Goodwin GM
    J Clin Psychiatry; 1996; 57 Suppl 4():9-13. PubMed ID: 8636065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of antidepressants.
    Kasper S; Fuger J; Möller HJ
    Drugs; 1992; 43 Suppl 2():11-22; discussion 22-3. PubMed ID: 1378369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects.
    Stahl SM
    J Affect Disord; 1998 Dec; 51(3):215-35. PubMed ID: 10333979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Care of depression in the elderly: comparative pharmacokinetics of SSRIs.
    Baumann P
    Int Clin Psychopharmacol; 1998 Sep; 13 Suppl 5():S35-43. PubMed ID: 9817619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacokinetics of selective serotonin reuptake inhibitors.
    van Harten J
    Clin Pharmacokinet; 1993 Mar; 24(3):203-20. PubMed ID: 8384945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective serotonin-reuptake inhibitors: an update.
    Masand PS; Gupta S
    Harv Rev Psychiatry; 1999; 7(2):69-84. PubMed ID: 10471245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of antidepressants: selectivity or multiplicity?
    Westenberg HG
    J Clin Psychiatry; 1999; 60 Suppl 17():4-8; discussion 46-8. PubMed ID: 10446734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluvoxamine. An updated review of its use in the management of adults with anxiety disorders.
    Figgitt DP; McClellan KJ
    Drugs; 2000 Oct; 60(4):925-54. PubMed ID: 11085201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressants in panic disorder: clinical and preclinical mechanisms.
    Nutt DJ
    J Clin Psychiatry; 1998; 59 Suppl 8():24-8; discussion 29. PubMed ID: 9707159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible serotonergic mechanisms underlying the antidepressant and anti-obsessive-compulsive disorder responses.
    Blier P; de Montigny C
    Biol Psychiatry; 1998 Sep; 44(5):313-23. PubMed ID: 9755353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors.
    Baumann P
    Clin Pharmacokinet; 1996 Dec; 31(6):444-69. PubMed ID: 8968657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted pharmacotherapy in depression management: comparative pharmacokinetics of fluoxetine, paroxetine and sertraline.
    Preskorn S
    Int Clin Psychopharmacol; 1994 Jun; 9 Suppl 3():13-9. PubMed ID: 7963446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.